Pinecone Therapies

Sell-side

Exclusive Financial Advisor, April 2020

Pinecone Therapies
Sale of Pinecone Therapies

Pine Cone Therapies, a treatment program provider for children, families and adults with autism, speech-language, intellectual delay, neurological and attention deficit disorders, has been acquired. Pine Cone Therapies will now be providing care to more than 10,000 patients annually across 21 states.

More Like This

Jul 2023

Sold Majority Stake in hg medical to Astorg Mid-Cap

Exclusive Financial Advisor

View Details >
May 2023
Jounce Therapeutics Logo

Acquired by Concentra Biosciences

Exclusive Financial Advisor

View Details >
Mar 2023

Smile Source, a Portfolio Company of Brazos Private Equity Partners, has Partnered with Incline Equity Partners

Exclusive Financial Advisor

View Details >